Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Equity

v3.22.1
Consolidated Statements of Equity - USD ($)
Total
Class B Common Stock
Series A Cumulative Redeemable Preferred Stock
Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Deficit
Non-controlling Interest
Beginning balance at Dec. 31, 2020 $ 149,399,827   $ 125,270,350 $ 13,652   $ 339,742,380 $ (315,626,555) $ 0
Beginning balance (in shares) at Dec. 31, 2020       13,651,521        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (10,694,263)           (12,299,571) 1,605,308
Series A preferred stock dividends (2,309,672)         (2,309,672)    
Common Stock dividends (682,576)         (682,576)    
Equity attributable to non-controlling interest (Note 3) 115,323,036             115,323,036
Ending balance (in shares) at Mar. 31, 2021       13,651,521        
Ending balance at Mar. 31, 2021 251,036,352   125,270,350 $ 13,652   336,750,132 (327,926,126) 116,928,344
Beginning balance at Dec. 31, 2021 263,631,523   129,525,675 $ 14,893 $ 684 338,302,735 (327,157,636) 122,945,172
Beginning balance (in shares) at Dec. 31, 2021   683,761   14,893,184 683,761      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 4,364,757           2,304,463 2,060,294
Series A preferred stock dividends (2,388,130)         (2,388,130)    
Common Stock dividends (744,659)         (744,659)    
Reinvestment of dividends paid to common stockholders (in shares)       67,444        
Reinvestment of dividends paid to common stockholders 207,053     $ 67   206,986    
Crimson cash distribution on A-1 Units $ (809,212)             (809,212)
Ending balance (in shares) at Mar. 31, 2022 14,960,628 683,761   14,960,628 683,761      
Ending balance at Mar. 31, 2022 $ 264,261,332   $ 129,525,675 $ 14,960 $ 684 $ 335,376,932 $ (324,853,173) $ 124,196,254